Therapeutics
QingQing Wu, MS
student
Hubei University of Chinese Medicine
Wuhan, China, Hubei, China (People's Republic)
Yufei Chong, MD
Doctor
Hubei Rehabilitation Hospital
Wuhan City, Hubei, China (People's Republic)
Yutong Zhang, MS
student
Hubei University of Chinese medicine
Wuhan City, Hubei, China (People's Republic)
Can Duan, PhD
Doctor
Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Wuhan City, Hubei, China (People's Republic)
Jingyi Gong, MD
Physician
Hubei Provincial Hospital of Directly Affiliated Institutions/Hubei Rehabilitation Hospital
Wuhan City, Hubei, China (People's Republic)
Wenguang Xia, PhD
Doctor
Hubei Rehabilitation Hospital
Wuhan City, Hubei, China (People's Republic)
To evaluate whether JianNao TongLuo granules (JNTL), a Chinese herbal formula, improve cognitive and related functional outcomes in older adults with mild cognitive impairment (MCI), and to determine whether these clinical effects are accompanied by changes in task-evoked prefrontal activation measured by functional near-infrared spectroscopy (fNIRS).
Design:
We conducted a 12-week randomized, double-blind, placebo-controlled trial in adults with MCI. Sixty-four participants were allocated 1:1 to receive JNTL or matching placebo in addition to usual care. Global cognition was assessed with the Montreal Cognitive Assessment (MoCA), and executive function with the Shape Trail Test (STT-A/B). Sleep and depressive symptoms were measured using the Pittsburgh Sleep Quality Index and Patient Health Questionnaire-9. Task-related prefrontal activation during a verbal fluency task was recorded with multichannel fNIRS, and beta values for oxyhemoglobin changes were derived using a general linear model. Group differences in change from baseline were analyzed using linear models adjusting for baseline scores.
Results:
Compared with placebo, the JNTL group showed greater improvement in MoCA scores (between-group mean difference 3.16, 95% CI 1.99–4.33, p< 0.001) and shorter STT-B completion times, indicating better executive function (p< 0.01). Sleep quality and depressive symptoms also improved more in the JNTL group. fNIRS revealed significantly increased task-evoked oxyhemoglobin responses in several channels over the left inferior frontal gyrus (Broca’s area) after JNTL treatment, whereas changes were minimal with placebo. No treatment-related adverse events were observed.
Conclusion:
JNTL improved global cognition, executive function and related symptoms in older adults with MCI and enhanced task-evoked activation of the left prefrontal cortex. These findings suggest that modulation of prefrontal networks may be an important mechanism underlying the cognitive benefits of this multi-target Chinese medicine intervention. JNTL may represent a promising adjunct to neurorehabilitation strategies for MCI, and its effects should be confirmed in larger and longer trials.